Australia Breaking News

Anna Edwards, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Apollo Asset Management co-President Scott Kleinman discusses the US economy, the rising cost of capital and why he sees valuation issues for legacy portfolio companies impacting returns. He speaks with Bloomberg's Guy Johnson from the sidelines of the IPEM conference in Paris.

Tikehau Capital co-founder Antoine Flamarion says there are now "less transactions" in the private equity sphere. He adds that secondary markets are "a massive trend." He speaks with Bloomberg's Guy Johnson from the sidelines of the IPEM Global event in Paris.

Capstone Copper (ASX:CSC) recorded a 3.6% share price increase after copper prices hit record highs for two consecutive sessions.

Red Sky Energy (ASX:ROG) will participate in the Yarrow North 1 well re-entry programme in South Australia.

Cobre (ASX:CBE) executed third-party ore purchase agreements with two regional copper oxide miners to boost processing volumes in Chile.

Meta unveiled a new artificial intelligence agent designed to carry out tasks on a user's behalf. Meta said the tool, called Muse, will assist with online shopping, buying movie tickets and scheduling appointments. Bloomberg Intelligence's Matthew Bloxham breaks down the situation.

Biome Australia (ASX:BIO) announced it will launch Biome Daily Probiotic 60 and Biome Daily Kids Probiotic 60 in the first half of FY27.

The US escalated its trade war with Canada following Ottawa's tariff retaliation. Washington moved to block imports of some products while placing new tariffs on others, as well as seeking to bar Canadian companies from selling to government contractors. Bloomberg's Rosalind Mathieson reports.

EBR Systems (ASX:EBR) announced that the U.S. Food and Drug Administration completed a review of its cybersecurity assessment.

Louis-Vincent Gave, CEO of Gavekal, discusses his outlook for investing in global markets. He speaks with Bloomberg's Stephen Engle on the sidelines of KBFG Korea Conference on "Bloomberg: The Asia Trade".

Neurizon Therapeutics (ASX:NUZ) announced that the US National Institutes of Health awarded a multi-year grant.